<document xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:z="http://www.ebi.ac.uk/z" source="Whatizit"><text><SENT sid="0" pm="."><plain>BACKGROUND: <z:e sem="disease" ids="C1527249" disease_type="Neoplastic Process" abbrv="">Colorectal cancers</z:e> often arise from benign <z:mpath ids='MPATH_491'>polyps</z:mpath> </plain></SENT>
<SENT sid="1" pm="."><plain><z:mpath ids='MPATH_490'>Adenomatous polyps</z:mpath> and serrated <z:mpath ids='MPATH_491'>polyps</z:mpath> progress step by step to <z:mp ids='MP_0009308'>adenocarcinoma</z:mp> and change into malignant <z:e sem="disease" ids="C1306459,C0006826" disease_type="Neoplastic Process" abbrv="">cancers</z:e> </plain></SENT>
<SENT sid="2" pm="."><plain>Genetic and epigenetic changes have correlation with specific stages of <z:mpath ids='MPATH_491'>polyp</z:mpath>-<z:mp ids='MP_0009308'>adenocarcinoma</z:mp> progression and <z:e sem="disease" ids="C1527249,C0009402" disease_type="Neoplastic Process" abbrv="">colorectal cancer</z:e> histopathological changes </plain></SENT>
<SENT sid="3" pm="."><plain>AIMS: In this study we used immunohistochemistry (IHC) staining in <z:hpo ids='HP_0003745'>sporadic</z:hpo> colorectal <z:mpath ids='MPATH_491'>polyps</z:mpath> to assay functional status of MLH1, MSH2, MSH6, and PMS2 proteins, to track genetic/epigenetic roles of this issue in our patients </plain></SENT>
<SENT sid="4" pm="."><plain>MATERIALS AND METHODS: In this cross-sectional study we assessed <z:hpo ids='HP_0000001'>all</z:hpo> patients who were admitted with <z:hpo ids='HP_0003745'>sporadic</z:hpo> colorectal <z:mpath ids='MPATH_491'>polyps</z:mpath> and underwent polypectomy in endoscopy department during 2004-2008 </plain></SENT>
<SENT sid="5" pm="."><plain>RESULT: IHC results were abnormal in 6.8% cases for MLH1, in 4.5% cases for MSH2, in 3% for MSH6, and in 4.8% for PMS2 </plain></SENT>
<SENT sid="6" pm="."><plain>In <z:hpo ids='HP_0000001'>all</z:hpo> cases with abnormal PMS2, MLH1 was also reported as abnormal </plain></SENT>
<SENT sid="7" pm="."><plain>Same results were reported for abnormal MSH2, which is accompanied with abnormal MSH6 in <z:hpo ids='HP_0000001'>all</z:hpo> cases (P values &lt; 0.001) </plain></SENT>
<SENT sid="8" pm="."><plain>There is no significant difference between IHC staining results, gender, <z:mpath ids='MPATH_589'>dysplasia</z:mpath> grade, adenomatous type, and invasion </plain></SENT>
<SENT sid="9" pm="."><plain>On the other hand, there was significant difference between IHC staining results, <z:mpath ids='MPATH_491'>polyp</z:mpath> location, and mean age of patients </plain></SENT>
<SENT sid="10" pm="."><plain>The same significant difference was between <z:mpath ids='MPATH_490'>adenomatous polyps</z:mpath> and serrated <z:mpath ids='MPATH_270'>adenoma</z:mpath> <z:mpath ids='MPATH_491'>polyps</z:mpath> by MLH1 and PMS2 (P values &lt; 0.05) </plain></SENT>
<SENT sid="11" pm="."><plain>CONCLUSION: According to our findings, maybe MMR dysfunction is the cause of <z:hpo ids='HP_0003745'>sporadic</z:hpo> colorectal <z:mpath ids='MPATH_491'>polyps</z:mpath> in younger age and its increasing risk of <z:mpath ids='MPATH_589'>dysplasia</z:mpath> progression and <z:e sem="disease" ids="C1306459,C0006826" disease_type="Neoplastic Process" abbrv="">malignancy</z:e> progression is only in serrated <z:mpath ids='MPATH_270'>adenoma</z:mpath> </plain></SENT>
<SENT sid="12" pm="."><plain><z:hpo ids='HP_0003745'>Sporadic</z:hpo> <z:mpath ids='MPATH_491'>polyps</z:mpath> in left colon had a higher risk to progress to <z:e sem="disease" ids="C0006826" disease_type="Neoplastic Process" abbrv="">malignancies</z:e>, and abnormal IHC staining for MLH1 and PMS2 in serrated <z:mpath ids='MPATH_491'>polyps</z:mpath> is much more than in other <z:mpath ids='MPATH_490'>adenomatous polyps</z:mpath> </plain></SENT>
</text></document>